当前位置:首页 - 行情中心 - 海正药业(600267) - 财务分析 - 现金流量表

海正药业

(600267)

  

流通市值:105.80亿  总市值:105.86亿
流通股本:11.98亿   总股本:11.99亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,722,682,572.5411,492,116,928.818,365,256,571.785,432,388,543.38
收到的税费返还2,041,364.0427,607,365.4751,151,542.7632,695,546.91
收到其他与经营活动有关的现金118,896,415.48386,382,736.34346,239,911.16269,955,017.46
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,843,620,352.0611,906,107,030.628,762,648,025.75,735,039,107.75
购买商品、接受劳务支付的现金1,432,232,724.075,668,161,777.534,133,920,000.212,760,110,618.39
支付给职工以及为职工支付的现金584,417,014.411,619,570,942.531,250,583,656.89883,848,186.77
支付的各项税费210,531,098.21653,679,236.69500,267,049.09321,452,818.93
支付其他与经营活动有关的现金353,732,450.381,850,162,521.391,422,297,458.74988,194,129.6
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,580,913,287.079,791,574,478.147,307,068,164.934,953,605,753.69
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额262,707,064.992,114,532,552.481,455,579,860.77781,433,354.06
二、投资活动产生的现金流量:
取得投资收益收到的现金-16,975,438.3615,910,438.3615,910,438.36
处置固定资产、无形资产和其他长期资产收回的现金净额3,044,406.4911,234,586.311,008,640.96883,857.53
收到的其他与投资活动有关的现金1,529,219.4530,006,181.6821,630,248.2620,319,651.65
投资活动现金流入的平衡项目0000
投资活动现金流入小计4,573,625.9458,216,206.3538,549,327.5837,113,947.54
购建固定资产、无形资产和其他长期资产支付的现金48,824,111.48238,441,690.76116,365,516.1866,351,425.99
投资支付的现金25,000,00039,234,450.4639,234,450.4630,000,000
支付其他与投资活动有关的现金1,086,791.41,340,0003,248,813.191,180,363.08
投资活动现金流出的平衡项目0000
投资活动现金流出小计74,910,902.88279,016,141.22158,848,779.8397,531,789.07
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-70,337,276.94-220,799,934.87-120,299,452.25-60,417,841.53
三、筹资活动产生的现金流量:
取得借款收到的现金569,343,2304,092,067,7963,152,000,0002,442,000,000
收到其他与筹资活动有关的现金-300,000,000300,000,000300,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计569,343,2304,392,067,7963,452,000,0002,742,000,000
偿还债务支付的现金613,000,0004,337,170,0002,947,021,551.782,033,051,551.78
分配股利、利润或偿付利息支付的现金27,731,374.33148,471,078.7112,231,571.1476,847,299.65
支付其他与筹资活动有关的现金1,679,317.361,943,371,911.021,866,982,094.271,555,708,298.55
筹资活动现金流出平衡项目0000
筹资活动现金流出小计642,410,691.696,429,012,989.724,926,235,217.193,665,607,149.98
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-73,067,461.69-2,036,945,193.72-1,474,235,217.19-923,607,149.98
四、汇率变动对现金及现金等价物的影响59,053.483,474,327.912,597,714.071,519,043.93
现金及现金等价物净增加额平衡项目-0.01-0.0100
五、现金及现金等价物净增加额119,361,379.83-139,738,248.21-136,357,094.6-201,072,593.52
加:期初现金及现金等价物余额1,189,884,406.71,329,622,654.911,329,622,654.911,329,622,654.91
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,309,245,786.531,189,884,406.71,193,265,560.311,128,550,061.39
补充资料:
净利润-591,311,870.59-434,029,470.93
资产减值准备-219,020,280.63-93,061,392.52
固定资产和投资性房地产折旧-884,578,982.87-453,832,460.95
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-884,578,982.87-453,832,460.95
无形资产摊销-188,708,557.99-84,395,172.73
长期待摊费用摊销-3,426,783.36-1,821,666.65
处置固定资产、无形资产和其他长期资产的损失--722,661.2--2,682,933.65
固定资产报废损失-1,272,666.38-558,089.14
公允价值变动损失-14,926,284.66-116,840.31
财务费用-151,270,555.46-86,205,462.99
投资损失--158,619,453.27--173,075,957.41
递延所得税-7,021,826.85-6,636,045.47
其中:递延所得税资产减少-4,401,215.35-5,134,362.67
递延所得税负债增加-2,620,611.5-1,501,682.8
存货的减少-69,128,178.62-200,636,452.02
经营性应收项目的减少-277,835,658.42--225,640,407.29
经营性应付项目的增加--241,501,563.2--189,216,232.62
其他-5,993,066.62-4,929,434.86
债务转为资本-429.26--
现金的期末余额-1,189,884,406.7-1,128,550,061.39
减:现金的期初余额-1,329,622,654.91-1,329,622,654.91
公告日期2025-04-172025-03-292024-10-312024-08-20
审计意见(境内)标准无保留意见
TOP↑